should be avoided. Class II solvents, such as methanol, pyridine, toluene,N,N-dimethylformamide, and acetonitrile have permitted daily exposure limits(PDEs). A few examples of <strong>com</strong>mon organic solvents which are found as volatileimpurities and have their limits set by ICH guidelines are depicted in Table 1. ClassIII solvents, such as acetic acid, acetone, isopropyl alcohol, butanol, ethanol, andethylacetate should be limited by GMP or other quality-based requirements.Table 1. ICH limits for a selected list of <strong>com</strong>mon organic solvents found as volatile impurities.Volatile Organic Impurity Limit (ppm) PDE (mg/day)Acetonitrile 410 4.1Chloroform 60 0.61,4-Dioxane 380 3.8Methylene chloride 600 6.0Pyridine 200 2.01,1,2-Trichloroethane 80 0.8USP 2009 General Chapter contains a more <strong>com</strong>prehensive method forresidual solvent <strong>analysis</strong> that is similar to the ICH guidelines developed in 1997.Here, a limit test is prescribed for class 1 and class 2 solvents while class 2Csolvents are usually determined by non headspace methods due to their higherboiling point. The limits of detection (LOD) re<strong>com</strong>mended for class 3 solvents areup to 5000 ppm. When the levels of residual solvents exceed USP or ICH limits,quantitation is required.NOTE: Regulatory limits for impurities mentioned in this document are given as examples and may not provide the <strong>com</strong>plete informationneeded. For <strong>com</strong>plete, current regulatory information and the latest updates, please check the websites of the various regulatory authorities.6
Selected Publications and Guidelines for the Control of Pharmaceutical ImpuritiesKey TopicsGuidelines for the control of impuritiesSpecific guidelines for the control of genotoxicimpuritiesGuidelines relevant to analytical methods forthe control of genotoxic impuritiesTitleInternational Conference on Harmonization (ICH) Q3A (R2) Impurities in New Drug Substances,25 October 2006ICH Q3B (R2) Impurities in New Drug Substances, 2 June 2006Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Re<strong>com</strong>mended approaches; USDepartment of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation andResearch (CDER); Silver Spring, MD, USA, December 2008EMA/CHMP/SWP/431994/2007 Rev. 3, Questions and answers on the guideline on the limits of genotoxicimpurities, adopted September 23, 2010Guideline on the Limits of Genotoxic Impurities, CPMP/SWP/5199/02, EMEA/CHMP/QWP/2513442006;Committee for Medicinal products (CHMP), European Medicines Agency (EMEA); London 28 June 2006Pharmeuropa, Vol 20, No. 3, July 2008, Potential Genotoxic Impurities and European Pharmacopoeiamonographs on Substances for Human UseICH M7 Guideline (in preparation) for control of Mutagenic genotoxic impuritiesICH Guidance for Industry: Pharmaceutical Development Q8, (R2); US Department of Health and HumanServices, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); Aug, 2009,http://www.fda.gov/RegulatoryInformation/Guidances/ucm128028.htmICH Guidelines, Q9: Quality Risk Management Q9; US Department of Health and Human Services. Foodand Drug Administration, Center for Drug Evaluation and Research (CDER): Rockville, MD, Nov, 2005,http://www.fda.gov/RegulatoryInformation/Guidances/ucm128050.htmICH S2A: Specific Aspects of Regulatory Genotoxicity Tests for Pharmaceuticals, April 1996ICH S2B: A Standard Battery for Genotoxicity Testing of Pharmaceuticals, July 1997ICH S2 (R1): DRAFT Consensus Guideline (Expected to <strong>com</strong>bine and replace ICH S2A and S2B): Guidance onGenotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use, March 6, 2008Guidelines for the control of elemental Elemental impurities – Limits (Pharm. Forum, 2011), 37 (3), Chapter impuritiesElemental impurities – Procedures (Pharm. Forum, 2011), 37(3), Chapter Guidelines for the control of residual solvents ICHQ3C, International Conference on Harmonization, Impurities Guidelines for Residual Solvents. FederalRegister, 62 (247), 1997, 67377International Conference on Harmonization, ICH Q3C (R3) Impurities: Guideline for Residual solvents,November 2005ICH Topic Q3C (R4) Impurities: Guideline for Residual Solvents, European Medicines Agency, 2010USP Method 467, US. Pharmacopeia, updated June 2007, USP 32 – NF 18NOTE: This list is a limited selection of key, recent regulatory publications. For <strong>com</strong>plete, current regulatory information and the latest updates, please check the websites of the various regulatory authorities.7